BioMark Diagnostics Overview
BioMark Diagnostics (BMKDF) has a PEG ratio of 315.88, above the sector sector average of 10.05.
Get informed when a big investor buys or sells
+ Follow315.88
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
BioMark Diagnostics posts a PEG ratio of 315.88. That is above the sector sector average of 10.05. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a PEG ratio near 10.05 is typical. BioMark Diagnostics's 315.88 is higher that level. That is roughly 3041.5% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
BioMark Diagnostics's PEG ratio of 315.88 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.
Context for BMKDF's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 10.05), and (3) consistency with growth and profitability. This page covers the first two; BioMark Diagnostics's other metric pages and overview cover the third.
